Skip to main content

Breast Cancer Research and Treatment

Ausgabe 2/2014

Inhalt (23 Artikel)

Review

Polyamines metabolism and breast cancer: state of the art and perspectives

Manuela Cervelli, Stefano Pietropaoli, Fabrizio Signore, Roberto Amendola, Paolo Mariottini

Review

Safety and efficacy of progressive resistance training in breast cancer: a systematic review and meta-analysis

Birinder S. Cheema, Sharon L. Kilbreath, Paul P. Fahey, Geoffrey P. Delaney, Evan Atlantis

Preclinical study

Generation of MCF-7 cells with aggressive metastatic potential in vitro and in vivo

Elke Ziegler, Marie-Therese Hansen, Maike Haase, Günter Emons, Carsten Gründker

Preclinical study

Small molecule 1′-acetoxychavicol acetate suppresses breast tumor metastasis by regulating the SHP-1/STAT3/MMPs signaling pathway

Jieqiong Wang, Li Zhang, Guoliang Chen, Jing Zhang, Zhenxi Li, Weiqiang Lu, Mingyao Liu, Xiufeng Pang

Preclinical Study

Emodin suppresses pulmonary metastasis of breast cancer accompanied with decreased macrophage recruitment and M2 polarization in the lungs

Xuemei Jia, Fang Yu, Junfeng Wang, Stephen Iwanowycz, Fatma Saaoud, Yuzhen Wang, Jun Hu, Qian Wang, Daping Fan

Preclinical study

Effects of Tamoxifen and oestrogen on histology and radiographic density in high and low mammographic density human breast tissues maintained in murine tissue engineering chambers

G. L. Chew, C. W. Huo, D. Huang, T. Blick, P. Hill, J. Cawson, H. Frazer, M. C. Southey, J. L. Hopper, K. Britt, M. A. Henderson, I. Haviv, E. W. Thompson

Open Access Preclinical study

Development of a robust RNA-based classifier to accurately determine ER, PR, and HER2 status in breast cancer clinical samples

Timothy R. Wilson, Yuanyuan Xiao, Jill M. Spoerke, Jane Fridlyand, Hartmut Koeppen, Eloisa Fuentes, Ling Y. Huw, Ilma Abbas, Arjan Gower, Erica B. Schleifman, Rupal Desai, Ling Fu, Teiko Sumiyoshi, Joyce A. O’Shaughnessy, Garret M. Hampton, Mark R. Lackner

Clinical trial

Differences in expression of proliferation-associated genes and RANKL across the menstrual cycle in estrogen receptor-positive primary breast cancer

Ben P. Haynes, Giuseppe Viale, Viviana Galimberti, Nicole Rotmensz, Bianca Gibelli, Ian E. Smith, Mitch Dowsett

Clinical trial

Anastrozole versus tamoxifen as adjuvant therapy for Japanese postmenopausal patients with hormone-responsive breast cancer: efficacy results of long-term follow-up data from the N-SAS BC 03 trial

Tomohiko Aihara, Isao Yokota, Yasuo Hozumi, Kenjiro Aogi, Hiroji Iwata, Motoshi Tamura, Atsushi Fukuuchi, Haruhiko Makino, Ryungsa Kim, Masashi Andoh, Koichiro Tsugawa, Shinji Ohno, Takuhiro Yamaguchi, Yasuo Ohashi, Toru Watanabe, Yuichi Takatsuka, Hirofumi Mukai

Clinical trial

Concurrent administration of trastuzumab with locoregional breast radiotherapy: long-term results of a prospective study

J. Jacob, L. Belin, J.-Y. Pierga, A. Gobillion, A. Vincent-Salomon, R. Dendale, P. Beuzeboc, F. Campana, A. Fourquet, Y. M. Kirova

Clinical trial

Frozen section evaluation of breast carcinoma sentinel lymph nodes: a retrospective review of 1,940 cases

Justin S. Poling, Theodore N. Tsangaris, Pedram Argani, Ashley Cimino-Mathews

Epidemiology

Metabolic syndrome and outcomes following early-stage breast cancer

Gregory S. Calip, Kathleen E. Malone, Julie R. Gralow, Andy Stergachis, Rebecca A. Hubbard, Denise M. Boudreau

Epidemiology

Racial and ethnic disparities in the diagnosis of breast cancer: changes in presenting stage in minority populations in Florida during 1981–2009

Austin R. Dosch, Tulay Koru-Sengul, Feng Miao, Stacey L. Tannenbaum, Margaret M. Byrne, Jean L. Wright

Epidemiology

Use of risk-reducing surgeries in a prospective cohort of 1,499 BRCA1 and BRCA2 mutation carriers

Xinglei Chai, Tara M. Friebel, Christian F. Singer, D. Gareth Evans, Henry T. Lynch, Claudine Isaacs, Judy E. Garber, Susan L. Neuhausen, Ellen Matloff, Rosalind Eeles, Nadine Tung, Jeffrey N. Weitzel, Fergus J. Couch, Peter J. Hulick, Patricia A. Ganz, Mary B. Daly, Olufunmilayo I. Olopade, Gail Tomlinson, Joanne L. Blum, Susan M. Domchek, Jinbo Chen, Timothy R. Rebbeck

Epidemiology

Racial differences in breast cancer, cardiovascular disease, and all-cause mortality among women with ductal carcinoma in situ of the breast

Amy Berkman, Bernard F. Cole, Philips A. Ades, Samantha Dickey, Higgins Stephen T., Amy Trentham-Dietz, Brian L. Sprague, Susan G. Lakoski

Epidemiology

Limited family structure and triple-negative breast cancer (TNBC) subtype as predictors of BRCA mutations in a genetic counseling cohort of early-onset sporadic breast cancers

Jon Zugazagoitia, Pedro Pérez-Segura, Arancha Manzano, Ignacio Blanco, Ana Vega, Ana Custodio, Alex Teulé, Laura Fachal, Beatriz Martínez, Rogelio González-Sarmiento, Juan Jesús Cruz-Hernández, Isabel Chirivella, Vicente Garcés, Pilar Garre, Atocha Romero, Trinidad Caldés, Eduardo Díaz-Rubio, Miguel de la Hoya

Epidemiology

High GINS2 transcript level predicts poor prognosis and correlates with high histological grade and endocrine therapy resistance through mammary cancer stem cells in breast cancer patients

Ming Zheng, Yinghui Zhou, Xiangmin Yang, Juan Tang, Ding Wei, Yang Zhang, Jian-Li Jiang, Zhi-nan Chen, Ping Zhu

Epidemiology

Impact of estrogen receptor (ER) and human epidermal growth factor receptor-2 (HER2) co-expression on breast cancer disease characteristics: implications for tumor biology and research

Abeer Alqaisi, Li Chen, Edward Romond, Mara Chambers, Mark Stevens, Grace Pasley, Mukta Awasthi, Suleiman Massarweh

Brief Report

Upper extremity bioimpedance before and after treadmill testing in women post breast cancer treatment

Betty Smoot, Sarah Zerzan, Joanne Krasnoff, Josephine Wong, Maria Cho, Marylin Dodd

Open Access Brief Report

Anti-nicastrin monoclonal antibodies elicit pleiotropic anti-tumour pharmacological effects in invasive breast cancer cells

Aleksandra Filipović, Ylenia Lombardo, Monica Fronato, Joel Abrahams, Eric Aboagye, Quang-De Nguyen, Barbara Borda d’Aqua, Anne Ridley, Andrew Green, Emad Rahka, Ian Ellis, Chiara Recchi, Natasa Przulj, Anida Sarajlić, Jean-Rene Alattia, Patrick Fraering, Mahendra Deonarain, R. Charles Coombes

Erratum

Erratum to: Anti-nicastrin monoclonal antibodies elicit pleiotropic anti-tumour pharmacological effects in invasive breast cancer cells

Aleksandra Filipović, Ylenia Lombardo, Monica Faronato, Joel Abrahams, Eric Aboagye, Quang-De Nguyen, Barbara Borda d’Aqua, Anne Ridley, Andrew Green, Emad Rahka, Ian Ellis, Chiara Recchi, Natasa Przulj, Anida Sarajlić, Jean-Rene Alattia, Patrick Fraering, Mahendra Deonarain, R. Charles Coombes

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.